SCHEMBL12015481

SCHEMBL12015481

CC(F)(F)C(=O)OC1CCCCC1N1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 3/20 0.40
▸ KCNA5 P22460 2/20 0.38
▸ SCN5A Q14524 2/20 0.38
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ RECQL P46063 1/20 0.33
▸ L3MBTL3 Q96JM7 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ USP2 O75604 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12015487 0.88 SLC18A3 (0.44) SLC18A3ALDH1A1OPRM1OPRK1
SCHEMBL12015482 0.87 SLC18A3 (0.43) SLC18A3ALDH1A1OPRM1OPRK1
SCHEMBL13174350 0.83 SLC18A3 (0.40) SLC18A3ALDH1A1OPRM1OPRK1
SCHEMBL12017268 0.83 SLC18A3 (0.36) SLC18A3KCNA5SCN5AL3MBTL3L3MBTL1
SCHEMBL12015508 0.80 SLC18A3 (0.34) SLC18A3KCNA5SCN5AALDH1A1HPGD
SCHEMBL12165452 0.77 SLC18A3 (0.39) SLC18A3KCNA5SCN5AL3MBTL3L3MBTL1
SCHEMBL12015489 0.74 KCNA5 (0.47) KCNA5SCN5AALDH1A1HPGD
SCHEMBL7793151 0.71 SLC18A3 (0.50) SLC18A3CNR2ALDH1A1SMN1; SMN2HPGD
SCHEMBL685770 0.71 NPY1R (0.39) ALDH1A1
SCHEMBL5523739 0.70 OPRM1 (0.49) SLC18A3KCNA5SCN5AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9176378-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-03 — — US disclosed
US-8921028-B2 Salt, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-30 — — US disclosed
US-8735047-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-27 — — US disclosed
US-8574812-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-11-05 — — US disclosed
US-8460851-B2 Salt and photoresist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-06-11 — — US disclosed
US-20130022919-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-24 — — US disclosed
US-20120258404-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-11 — — US disclosed
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-13 — — US disclosed
US-20120219906-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 — — US disclosed
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, RCOR3, REN SLC18A3 3552/4885KCNA5 616/4885SCN5A 525/4885
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME CLIC1, SLC10A6, APOL1 SLC18A3 2876/4885KCNA5 798/4885SCN5A 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback